Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5235
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWickramarachchi, Thilan-
dc.contributor.authorPremaratne, Prasad H.-
dc.contributor.authorPerera, K. L. R. Lakshman-
dc.contributor.authorBandara, Sumith-
dc.contributor.authorThomas, Alan W.-
dc.contributor.authorHandunnetti, Shiroma M.-
dc.contributor.authorUdagama-Randeniya, Preethi V.-
dc.date.accessioned2021-06-05T10:15:12Z-
dc.date.available2021-06-05T10:15:12Z-
dc.date.issued2005-
dc.identifier.citation27en_US
dc.identifier.otherdoi:10.1128/IAI.74.1.798–801.2006-
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/5235-
dc.description.abstractPlasmodium vivax apical membrane antigen 1, an important malaria vaccine candidate, was immunogenic during natural malaria infections in Sri Lanka, where low transmission and unstable malaria conditions prevail. Antibody prevalence increased with exposure in areas where malaria was or was not endemic. A marked isotype switch to cytophilic (immunoglobulin G1 [IgG1]/IgG3) antibodies was evident with increasing exposure exclusively in residents from areas of endemicity.en_US
dc.description.sponsorshipThis work was supported by the National Science Foundation, Sri Lanka (grant no. SIDA/99/BT/01), and the International Foundation for Science, Sweden (grant no. W3008-1).en_US
dc.language.isoenen_US
dc.publisherINFECTION AND IMMUNITYen_US
dc.subjectPlasmodium vivaxen_US
dc.subjectApical Membraneen_US
dc.subjectMalariaen_US
dc.subjectApical Membrane Antigen 1en_US
dc.titleNatural Human Antibody Responses to Plasmodium vivax Apical Membrane Antigen 1 under Low Transmission and Unstable Malaria Conditions in Sri Lankaen_US
dc.typeArticleen_US
Appears in Collections:Department of Zoology

Files in This Item:
File Description SizeFormat 
16.pdfMain article56.98 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.